PGIOX
Price
$38.46
Change
-$0.68 (-1.74%)
Updated
Nov 13 closing price
Net Assets
730.98M
RGEBX
Price
$83.30
Change
-$1.87 (-2.20%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

PGIOX vs RGEBX

Header iconPGIOX vs RGEBX Comparison
Open Charts PGIOX vs RGEBXBanner chart's image
Putnam Focused Equity R
Price$38.46
Change-$0.68 (-1.74%)
VolumeN/A
Net Assets730.98M
American Funds Growth Fund of Amer R2E
Price$83.30
Change-$1.87 (-2.20%)
VolumeN/A
Net Assets340.4B
PGIOX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
PGIOX vs. RGEBX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGIOX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 340B vs. PGIOX (731M). PGIOX (0.00) and RGEBX (0.00) have matching dividends . PGIOX was incepted earlier than RGEBX: PGIOX (17 years) vs RGEBX (11 years). PGIOX (1.36) is less costly to investors than RGEBX (1.09). PGIOX is a more actively managed with annual turnover of: 30.00 vs. RGEBX (25.00). PGIOX has a lower initial minimum investment than RGEBX: PGIOX (0) vs RGEBX (250). RGEBX annual gain was more profitable for investors over the last year : 8.10 vs. PGIOX (6.65). PGIOX return over 5 years is better than : 62.20 vs. RGEBX (36.65).
PGIOXRGEBXPGIOX / RGEBX
Total Expense Ratio1.361.09125%
Annual Report Gross Expense Ratio1.361.09125%
Fund Existence17 years11 years-
Gain YTD18.93019.21998%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets731M340B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.658.1082%
Returns for 3 years56.4862.3991%
Returns for 5 years62.2036.65170%
Returns for 10 years145.7293.78155%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRUG60.150.91
+1.54%
Bright Minds Biosciences
SRPT18.000.02
+0.11%
Sarepta Therapeutics
WSBCP24.98N/A
N/A
WesBanco
XP19.21-0.59
-2.98%
XP
HKIT2.37-0.39
-14.13%
Hitek Global